Literature DB >> 7517160

Serum copper and zinc in industrial centers in Slovakia.

T Magalova1, A Brtkova, A Bederova, I Kajaba, I Puchonova.   

Abstract

The association between serum copper and zinc concentrations and age, sex, and other risk factors of cardiovascular disease in randomly selected adult volunteers aged 19-59 were investigated. There was a positive relationship between copper and age in both sexes, but zinc was negatively correlated with age in males only. Serum zinc was positively related to HDL-cholesterol in males. Serum copper was positively related to total cholesterol and LDL-cholesterol but negatively correlated to HDL-cholesterol in males. A positive relationship to body mass index was observed in females only. Subjects have been divided into a control group and a group with marked risk factors of cardiovascular disease. The levels of zinc were not different, whereas the levels of copper in both males and females were significantly higher in the risk group. Our results suggested a positive relationship between serum copper and cumulation of more factors of cardiovascular disease, however, their causal effect in human has to be investigated further.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517160     DOI: 10.1007/bf02950795

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  25 in total

1.  Coronary heart disease: the zinc/copper hypothesis.

Authors:  L M Klevay
Journal:  Am J Clin Nutr       Date:  1975-07       Impact factor: 7.045

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Whole blood and serum zinc levels in relation to sex and age.

Authors:  S C Buxaderas; R Farré-Rovira
Journal:  Rev Esp Fisiol       Date:  1985-12

4.  Serum copper and zinc in random samples of the population of Northern Ireland.

Authors:  D McMaster; E McCrum; C C Patterson; M M Kerr; D O'Reilly; A E Evans; A H Love
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

5.  Cholesterolemia and cardiovascular abnormalities in rats caused by copper deficiency.

Authors:  K G Allen; L M Klevay
Journal:  Atherosclerosis       Date:  1978-01       Impact factor: 5.162

6.  Cholesterol determination in high-density lipoproteins separated by three different methods.

Authors:  M F Lopes-Virella; P Stone; S Ellis; J A Colwell
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

7.  Increased cholesterol in plasma in a young man during experimental copper depletion.

Authors:  L M Klevay; L Inman; L K Johnson; M Lawler; J R Mahalko; D B Milne; H C Lukaski; W Bolonchuk; H H Sandstead
Journal:  Metabolism       Date:  1984-12       Impact factor: 8.694

8.  Relationship between zinc intake, physical activity, and blood levels of high-density lipoprotein cholesterol in a healthy elderly population.

Authors:  J S Goodwin; W C Hunt; P Hooper; P J Garry
Journal:  Metabolism       Date:  1985-06       Impact factor: 8.694

9.  Serum copper and zinc and the risk of death from cancer and cardiovascular disease.

Authors:  F J Kok; C M Van Duijn; A Hofman; G B Van der Voet; F A De Wolff; C H Paays; H A Valkenburg
Journal:  Am J Epidemiol       Date:  1988-08       Impact factor: 4.897

10.  Copper and zinc in human serum in Norway. Relationship to geography, sex and age.

Authors:  K Helgeland; T Haider; J Jonsen
Journal:  Scand J Clin Lab Invest       Date:  1982-02       Impact factor: 1.713

View more
  2 in total

1.  The Evaluation of Micronutrients and Oxidative Stress and their Relationship with the Lipid Profile in Healthy adults.

Authors:  Narasimha Rai K; N Suchetha Kumari; Damodara Gowda Km; Swathi Kr
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  Clinical factors associated with serum copper levels and potential effect of sevelamer in hemodialysis patients.

Authors:  Ryota Ikee; Masataka Tsunoda; Naomi Sasaki; Naritsugu Sato; Nobuo Hashimoto
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.